These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 16368286

  • 1. Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: results from 4 large clinical trials.
    Galla JM, Mahaffey KW, Sapp SK, Alexander JH, Roe MT, Ohman EM, Granger CB, Armstrong PW, Harrington RA, White HD, Simoons ML, Newby LK, Califf RM, Topol EJ.
    Am Heart J; 2006 Jan; 151(1):16-24. PubMed ID: 16368286
    [Abstract] [Full Text] [Related]

  • 2. Creatine kinase-MB elevation after coronary artery bypass grafting surgery in patients with non-ST-segment elevation acute coronary syndromes predict worse outcomes: results from four large clinical trials.
    Mahaffey KW, Roe MT, Kilaru R, Alexander JH, Van de Werf F, Califf RM, Simoons ML, Topol EJ, Harrington RA.
    Eur Heart J; 2007 Feb; 28(4):425-32. PubMed ID: 17267458
    [Abstract] [Full Text] [Related]

  • 3. Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.
    Figiel Ł, Kasprzak JD, Peruga J, Lipiec P, Drozdz J, Krzemińska-Pakuła M, Smigielski J.
    Kardiol Pol; 2008 Mar; 66(3):253-9, discussion 260-1. PubMed ID: 18393112
    [Abstract] [Full Text] [Related]

  • 4. Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes.
    Roe MT, Mahaffey KW, Kilaru R, Alexander JH, Akkerhuis KM, Simoons ML, Harrington RA, Tardiff BE, Granger CB, Ohman EM, Moliterno DJ, Lincoff AM, Armstrong PW, Van de Werf F, Califf RM, Topol EJ.
    Eur Heart J; 2004 Feb; 25(4):313-21. PubMed ID: 14984920
    [Abstract] [Full Text] [Related]

  • 5. Frequency and clinical implications of discordant creatine kinase-MB and troponin measurements in acute coronary syndromes.
    Newby LK, Roe MT, Chen AY, Ohman EM, Christenson RH, Pollack CV, Hoekstra JW, Peacock WF, Harrington RA, Jesse RL, Gibler WB, Peterson ED, CRUSADE Investigators.
    J Am Coll Cardiol; 2006 Jan 17; 47(2):312-8. PubMed ID: 16412853
    [Abstract] [Full Text] [Related]

  • 6. Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Nienhuis MB, Ottervanger JP, de Boer MJ, Dambrink JH, Hoorntje JC, Gosselink AT, Suryapranata H, van't Hof AW, Zwolle Myocardial Infarction Study Group.
    Am Heart J; 2008 Apr 17; 155(4):673-9. PubMed ID: 18371475
    [Abstract] [Full Text] [Related]

  • 7. Troponin is more useful than creatine kinase in predicting one-year mortality among acute coronary syndrome patients.
    Yan AT, Yan RT, Tan M, Chow CM, Fitchett D, Stanton E, Langer A, Goodman SG, Canadian Acute Coronary Syndromes (ACS) Registry Investigators.
    Eur Heart J; 2004 Nov 17; 25(22):2006-12. PubMed ID: 15541836
    [Abstract] [Full Text] [Related]

  • 8. The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: lessons from the Global Registry of Acute Coronary Events (GRACE).
    Goodman SG, Steg PG, Eagle KA, Fox KA, López-Sendón J, Montalescot G, Budaj A, Kennelly BM, Gore JM, Allegrone J, Granger CB, Gurfinkel EP, GRACE Investigators.
    Am Heart J; 2006 Mar 17; 151(3):654-60. PubMed ID: 16504627
    [Abstract] [Full Text] [Related]

  • 9. Comparison of site-reported and core laboratory-reported creatine kinase-MB values in non-ST-segment elevation acute coronary syndrome (from the international trial SYNERGY).
    Linefsky JP, Lin M, Pieper KS, Reist CJ, Berdan LG, Antman EM, Goodman SG, French JK, Guneri S, Roe MT, Newby LK, Harrington RA, Ferguson JJ, Califf RM, Mahaffey KW.
    Am J Cardiol; 2009 Nov 15; 104(10):1330-5. PubMed ID: 19892046
    [Abstract] [Full Text] [Related]

  • 10. Elevated CK-MB values after routine angioplasty predicts worse long-term prognosis in low-risk patients.
    Vikenes K, Melberg T, Farstad M, Nordrehaug JE.
    Scand Cardiovasc J; 2010 Apr 15; 44(2):69-75. PubMed ID: 19670037
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Timing of death and myocardial infarction in patients with non-ST elevation acute coronary syndromes: insights from randomized clinical trials.
    Mehta RH, Greenbaum AB, Lokhnygina Y, Newby LK, Van De Werf F, Armstrong PW, Pieper KS, Califf RM, Granger CB, Harrington RA.
    J Interv Cardiol; 2007 Oct 15; 20(5):299-306. PubMed ID: 17880325
    [Abstract] [Full Text] [Related]

  • 19. Increased creatine kinase MB level predicts postoperative mortality after cardiac surgery independent of new Q waves.
    Ramsay J, Shernan S, Fitch J, Finnegan P, Todaro T, Filloon T, Nussmeier NA.
    J Thorac Cardiovasc Surg; 2005 Feb 15; 129(2):300-6. PubMed ID: 15678039
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.